Cross-Site Scripting (XSS) in Offiria
Advisory ID: | HTB23210 |
Product: | Offiria |
Vendor: | Slashes & Dots Sdn Bhd. |
Vulnerable Versions: | 2.1.0 and probably prior |
Tested Version: | 2.1.0 |
Advisory Publication: | April 2, 2014 [without technical details] |
Vendor Notification: | April 2, 2014 |
Public Disclosure: | May 7, 2014 |
Vulnerability Type: | Cross-Site Scripting [CWE-79] |
CVE Reference: | CVE-2014-2689 |
Risk Level: | Medium |
CVSSv2 Base Score: | 4.3 (AV:N/AC:M/Au:N/C:N/I:P/A:N) |
Solution Status: | Solution Available |
Discovered and Provided: | High-Tech Bridge Security Research Lab |
Advisory Details: | |
High-Tech Bridge Security Research Lab discovered vulnerability in Offiria, which can be exploited to perform Cross-Site Scripting (XSS) attacks against users of vulnerable application. | |
Solution: | |
Currently we are not aware of any official solution for this vulnerability. The vendor did not respond to: - 6 notifications by email - 1 notification via twitter - 1 notification via GitHub As a temporary solution it is recommended to remove the vulnerable script or restrict access to it via .htaccess file or WAF. | |
References: | |
[1] High-Tech Bridge Advisory HTB23210 - https://www.immuniweb.com/advisory/HTB23210 - Cross-Site Scripting (XSS) in Offiria. [2] Offiria - https://offiria.com - Offiria is a private, secure Enterprise Social Network for your organization. [3] Common Vulnerabilities and Exposures (CVE) - http://cve.mitre.org/ - international in scope and free for public use, CVE® is a dictionary of publicly known information security vulnerabilities and exposures. [4] Common Weakness Enumeration (CWE) - http://cwe.mitre.org - targeted to developers and security practitioners, CWE is a formal list of software weakness types. [5] ImmuniWeb® - Leveraging the power of machine-learning and genius of human brain to deliver the most advanced web application security and penetration testing. [6] ImmuniWeb® SSLScan - Test your servers for security and compliance with PCI DSS, HIPAA and NIST. | |
Please feel free to send us any additional information related to this Advisory, such as vulnerable versions, additional exploitation details and conditions, patches and other relevant details.